GO:1900182 positive regulation of protein localization to nucleus: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900182 describes any process that increases the frequency, rate, or extent of protein localization to the nucleus [1, 2].
• Nuclear translocation is often triggered by post-translational modifications, such as phosphorylation or dephosphorylation, that expose or mask nuclear localization signals [5, 8].
• Key regulatory proteins include ACSS2, YAP, AHR, NSUN2, BZR1, and TP53INP2, which shuttle between cytoplasm and nucleus to control transcription [1, 2, 3, 4, 5, 8].
• Dysregulation of nuclear localization contributes to cancer, metabolic disorders, developmental defects, and neurodegeneration [1, 2, 3, 4].
• CRISPR knockout, knock-in, and overexpression models are essential to dissect the causal role of transport regulators [2, 5, 8].
• EDITGENE provides end-to-end CRISPR services, including library screening and bioinformatics, to study nuclear localization pathways.
Description
The Gene Ontology (GO) term GO:1900182, positive regulation of protein localization to nucleus, defines any process that activates or increases the frequency, rate, or extent of protein localization to the nucleus [1, 2]. This biological process is fundamental to signal transduction, as many transcription factors and signaling effectors must enter the nucleus to initiate gene expression programs. For example, nuclear translocation of ACSS2 promotes lysosomal biogenesis and autophagy by supporting histone acetylation in the nucleus. Similarly, the Hippo pathway effector YAP relies on nuclear localization to regulate bone homeostasis, and its mislocalization is linked to skeletal defects. Researchers study GO:1900182 to understand how cells convert cytoplasmic signals into nuclear responses. The process is highly regulated and often depends on nuclear localization signals (NLS) and cytoplasmic retention motifs that are controlled by phosphorylation, proteolysis, or binding partners [5, 8]. For instance, the scaffold protein RACK1 modulates the nuclear localization of BZR1 in plants, illustrating evolutionary conservation of regulatory logic. In mammals, sphingosine kinase 2 regulates aryl hydrocarbon receptor (AHR) nuclear translocation and target gene activation, linking lipid signaling to xenobiotic responses. Dysregulation of nuclear localization is implicated in cancer, metabolic diseases, and neurological disorders [1, 2, 3, 4]. Therefore, precise experimental models are needed to dissect the molecular players and to identify therapeutic targets. This article integrates QuickGO annotations with verified PubMed literature to provide a research-grade overview of GO:1900182, its mechanisms, key genes, and methods for investigation.
positive regulation of protein localization to nucleus At A Glance
| GO ID | GO:1900182 |
|---|---|
| GO term | positive regulation of protein localization to nucleus |
| Ontology | biological_process |
| Synonym | activation of protein localization to nucleus; upregulation of protein localization to nucleus; positive regulation of protein localization in nucleus |
| Major function | Increases the frequency, rate, or extent of protein transport into the nucleus, often in response to signaling cues [1, 2, 3]. |
| Related process | Regulation of nuclear import; signal transduction; transcription factor activation [5, 8]. |
| Key regulators | ACSS2, YAP, AHR, NSUN2, BZR1, TP53INP2, RACK1, sphingosine kinase 2 [1, 2, 3, 4, 5, 8]. |
| Disease relevance | Cancer, metabolic disorders, bone homeostasis, cognitive function [1, 2, 3, 4]. |
What Is GO:1900182?
GO:1900182, positive regulation of protein localization to nucleus, is a biological process term that encompasses any molecular event that enhances the movement of a protein into the nucleus. This includes activation of nuclear import receptors, modification of cargo proteins to expose nuclear localization signals, or relief of cytoplasmic retention [5, 8]. The term is distinct from the basal process of protein localization to nucleus (GO:0006606) because it specifically refers to positive regulatory inputs that increase the efficiency or rate of nuclear import [1, 2].
Why Is positive regulation of protein localization to nucleus Important in Cell Biology?
Understanding positive regulation of protein localization to nucleus is critical because nuclear entry is a decisive step in many signaling pathways. It controls gene expression programs that govern cell growth, metabolism, stress responses, and differentiation [1, 2, 3, 5]. Defects in this process can lead to inappropriate activation of oncogenes or loss of tumor suppressors, contributing to cancer and other diseases [1, 2, 3, 4]. Moreover, nuclear localization is a dynamic and reversible event, making it an attractive target for therapeutic intervention. Researchers need robust models to identify regulators and to test causality, which is where CRISPR-based approaches become indispensable [2, 5, 8].
• Nuclear localization of transcription factors such as YAP and AHR directly controls gene expression programs in development and disease [2, 3].
• ACSS2 nuclear translocation links metabolic state to epigenetic regulation and autophagy.
• NSUN2 nuclear import affects tRNA modification and cognitive function, highlighting roles beyond transcription.
• RACK1-mediated nuclear localization of BZR1 is essential for brassinosteroid signaling in plants.
• TP53INP2 nuclear import is regulated by a C-terminal cytoplasmic retention motif and NLS, providing a paradigm for cargo-specific control.
• Dysregulation of nuclear transport is associated with cancer, neurodegeneration, and metabolic syndromes [1, 2, 3, 4].
• CRISPR screens can identify novel regulators of nuclear localization, accelerating target discovery [2, 5].
• Small molecules that modulate nuclear import are being explored as therapeutics, underscoring the need for mechanistic studies [3, 6].
What Happens During positive regulation of protein localization to nucleus?
Signal-Induced Modification of Cargo Proteins
In simple terms: A protein gets a chemical tag that tells it to go to the nucleus.
Many cargo proteins are retained in the cytoplasm until a specific signal triggers post-translational modifications. For example, phosphorylation of BZR1 by upstream kinases is modulated by RACK1, which affects its nuclear localization. Similarly, ACSS2 is translocated to the nucleus in response to metabolic cues, where it promotes gene transcription. These modifications often expose or create a nuclear localization signal (NLS) that is recognized by import receptors.
Recognition by Nuclear Transport Receptors
In simple terms: A shuttle protein grabs the cargo and carries it through the nuclear pore.
Importins (karyopherins) recognize NLS motifs on cargo proteins and mediate their transport through the nuclear pore complex. The regulation of this step can involve changes in the affinity of importins for cargo or in the availability of importins themselves. For instance, the nuclear import of TP53INP2 is regulated by a C-terminal cytoplasmic retention motif that must be overcome for importin binding. Positive regulation of protein localization to nucleus often involves enhancing this recognition step [5, 8].
Release from Cytoplasmic Anchors
In simple terms: The protein is freed from a tether that was holding it in the cytoplasm.
Many proteins are anchored in the cytoplasm through interactions with retention factors or structural elements. Positive regulation can involve the disruption of these interactions. For example, sphingosine kinase 2 regulates the nuclear translocation of AHR, likely by modulating its release from cytoplasmic complexes. Similarly, stress granules can sequester proteins and regulate their availability for nuclear import. The disassembly of such anchors is a key regulatory step [3, 7].
Nuclear Pore Complex Transit and Intranuclear Retention
In simple terms: The cargo moves through the pore and then stays in the nucleus.
Once at the nuclear pore, the cargo-receptor complex translocates into the nucleus. Positive regulation can also occur at the level of intranuclear retention, where proteins are prevented from returning to the cytoplasm. For instance, nuclear ACSS2 is retained in the nucleus to support histone acetylation and transcription. The balance between import and export determines the steady-state nuclear localization, and positive regulators can tip this balance toward nuclear accumulation [1, 8].
Integration with Cellular Stress and Metabolic States
In simple terms: The cell's health and energy status influence whether proteins go to the nucleus.
Nuclear localization is often coupled to cellular stress and metabolic status. Stress granules, for example, can regulate the assembly of paraspeckles and influence nuclear processes. NSUN2-mediated tRNA modification affects cognitive function, and its spatial regulation may impact nuclear import of specific factors. Metabolic enzymes like ACSS2 directly link nutrient availability to nuclear gene regulation. Thus, positive regulation of protein localization to nucleus is integrated with broader cellular physiology [1, 4, 7].
Key Genes Involved in GO:1900182 positive regulation of protein localization to nucleus
The following genes and proteins are experimentally validated regulators or cargoes of positive regulation of protein localization to nucleus, based on the provided literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ACSS2 | Nuclear translocated ACSS2 promotes gene transcription for lysosomal biogenesis and autophagy. | Links metabolism to epigenetic regulation; potential target in cancer and neurodegeneration. |
| YAP | Snhg18 regulates Yap subcellular localization to maintain bone homeostasis. | Hippo pathway effector; nuclear YAP drives proliferation; mislocalization linked to skeletal defects. |
| AHR | Sphingosine kinase 2 regulates AHR nuclear translocation and target gene activation. | Xenobiotic sensor; nuclear AHR controls detoxification and immune responses. |
| NSUN2 | Spatial regulation of NSUN2-mediated tRNA m5C installation in cognitive function. | RNA modification enzyme; nuclear import may affect tRNA processing and cognition. |
| BZR1 | RACK1 regulates BR signaling by modulating nuclear localization of BZR1. | Plant transcription factor; model for signal-dependent nuclear import. |
| TP53INP2 | C-terminal cytoplasmic retention motif and NLS regulate nuclear import of TP53INP2. | Autophagy regulator; nuclear import controls its function. |
| RACK1 | Scaffold protein that modulates nuclear localization of BZR1. | Regulator of nuclear import; potential target for modulating signaling. |
| Sphingosine kinase 2 | Regulates AHR nuclear translocation. | Lipid kinase; links sphingolipid signaling to nuclear import. |
| Protein kinase C | Involved in cell cycle modulation, potentially affecting nuclear localization. | Signaling kinase; may regulate nuclear transport of cell cycle regulators. |
| Snhg18 | Regulates Yap subcellular localization. | Long non-coding RNA; modulator of Hippo pathway. |
| Importins | Recognize NLS and mediate nuclear import. | Core machinery; targets for broad regulation. |
| Stress granule proteins | Regulate stress-induced paraspeckle assembly. | Link stress responses to nuclear organization. |
How Is positive regulation of protein localization to nucleus Regulated?
Positive regulation of protein localization to nucleus is controlled by multiple layers of regulation. Post-translational modifications, such as phosphorylation, can alter the exposure of NLS or cytoplasmic retention motifs [5, 8]. Signaling pathways, including sphingolipid signaling via sphingosine kinase 2, directly influence the nuclear translocation of AHR. Metabolic cues regulate ACSS2 nuclear entry, coupling nutrient status to gene expression. Additionally, stress granules can sequester proteins and modulate their nuclear availability. The scaffold protein RACK1 provides a platform for regulated nuclear import of BZR1 in plants. These diverse mechanisms ensure that nuclear localization is tightly coordinated with cellular physiology.
positive regulation of protein localization to nucleus and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ACSS2 | Cancer, autophagy, lysosomal biogenesis | Knockout and overexpression in cancer cell lines; autophagy flux assays |
| YAP | Bone homeostasis, skeletal defects | Knockout mouse models; bone marrow stromal cells |
| AHR | Xenobiotic response, cancer | Knockout and point mutation in hepatoma cells; AHR target gene reporter |
| NSUN2 | Cognitive function, neurodevelopmental disorders | Conditional knockout in neurons; tRNA modification profiling |
| TP53INP2 | Autophagy, metabolic disorders | Knock-in of NLS mutants; autophagy assays |
Cancer and Metabolic Reprogramming
Nuclear ACSS2 promotes lysosomal biogenesis and autophagy, processes that support tumor cell survival under metabolic stress. Dysregulated nuclear localization of YAP leads to uncontrolled cell proliferation and is implicated in various cancers. AHR nuclear translocation, regulated by sphingosine kinase 2, can promote tumorigenesis through target gene activation. Thus, targeting nuclear import pathways may offer therapeutic opportunities in oncology [1, 2, 3].
Neurological and Cognitive Disorders
NSUN2-mediated tRNA m5C installation is spatially regulated and affects cognitive function; defects in its nuclear import or localization may contribute to neurodevelopmental disorders. Protein kinase C involvement in cell cycle modulation suggests that nuclear transport defects could impact neuronal differentiation and survival. Understanding these mechanisms may reveal new targets for neurodegeneration [4, 6].
Bone Homeostasis and Skeletal Diseases
Snhg18 regulates Yap subcellular localization to maintain bone homeostasis; disruption of this axis leads to skeletal abnormalities. This highlights the importance of nuclear localization in tissue-specific stem cell differentiation and bone remodeling.
Autophagy and Lysosomal Storage Disorders
TP53INP2 nuclear import is regulated by a C-terminal cytoplasmic retention motif and NLS; its nuclear function is linked to autophagy regulation. ACSS2 nuclear translocation also promotes autophagy and lysosomal biogenesis. Defects in these pathways may contribute to lysosomal storage disorders and neurodegenerative diseases [1, 8].
From positive regulation of protein localization to nucleus-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate nuclear localization of Y? | CRISPR knockout of gene X followed by imaging of Y [2, 5] |
| Which domain of protein Y is required for nuclear import? | Point mutations in NLS or retention motifs |
| Does a disease-associated mutation affect nuclear localization? | Knock-in of the mutation using CRISPR |
| Where and when does protein Y enter the nucleus? | Tagged knock-in with fluorescent protein [1, 2] |
| Can overexpression of regulator Z enhance nuclear import? | Overexpression via lentiviral transduction [1, 3] |
| What are the global transcriptional consequences of nuclear import? | RNA-seq after knockout or overexpression [1, 2] |
How to Study the positive regulation of protein localization to nucleus Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Nuclear-to-cytoplasmic ratio of tagged proteins | Visualizing translocation in live cells [1, 2] |
| Subcellular fractionation | Protein levels in nuclear vs cytoplasmic extracts | Validating endogenous protein localization [1, 3, 8] |
| RNA-seq | Global gene expression changes | Identifying downstream transcriptional programs [1, 2] |
| Proteomics | Protein composition of nuclear fractions | Discovering cargo and interactors [1, 4] |
| CRISPR knockout screen | Loss-of-function effects on nuclear localization | Unbiased discovery of regulators [2, 5] |
| CRISPR activation screen | Gain-of-function effects on nuclear localization | Identifying enhancers of nuclear import [2, 5] |
| tRNA modification profiling | Levels of m5C in tRNA | Linking NSUN2 function to nuclear import |
| Autophagy flux assays | LC3 turnover and lysosomal activity | Assessing functional consequences of nuclear import [1, 8] |
Imaging-Based Nuclear Translocation Assays
Fluorescence microscopy of GFP- or mCherry-tagged proteins is the gold standard to visualize nuclear localization in live or fixed cells [1, 2, 5]. High-content imaging can quantify nuclear-to-cytoplasmic ratios across thousands of cells, enabling screens for regulators [2, 5]. For example, Snhg18 regulation of YAP localization was demonstrated using imaging.
Subcellular Fractionation and Western Blotting
Biochemical separation of nuclear and cytoplasmic fractions followed by immunoblotting provides a complementary method to assess nuclear localization [1, 3, 8]. This approach is particularly useful when antibodies for the protein of interest are available and can detect endogenous proteins [1, 8].
Transcriptomic and Proteomic Profiling
RNA-seq after manipulating nuclear localization regulators can reveal downstream gene expression changes [1, 2]. Proteomics of nuclear fractions can identify cargo proteins and interaction partners [1, 4]. For instance, ACSS2 nuclear function was linked to lysosomal gene expression via RNA-seq.
CRISPR Screens for Regulators of Nuclear Localization
Genome-wide CRISPR knockout or activation screens coupled with a nuclear translocation reporter can identify novel regulators of GO:1900182 [2, 5]. Such screens have been used to uncover lncRNAs like Snhg18 that modulate YAP localization. These unbiased approaches are powerful for discovering new components of the nuclear import machinery [2, 5].
How CRISPR Can Be Used to Study GO:1900182 positive regulation of protein localization to nucleus
Knockout
CRISPR knockout of candidate regulators (e.g., Snhg18, sphingosine kinase 2) can abolish nuclear localization of cargo proteins, providing causal evidence [2, 3]. Knockout cell lines are also used to identify compensatory pathways and to test drug sensitivity [2, 3].
Point Mutation
Introducing point mutations in NLS or cytoplasmic retention motifs (e.g., in TP53INP2) can precisely dissect the sequence requirements for nuclear import. Such models are invaluable for studying disease-associated mutations that alter localization.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) at endogenous loci allows real-time tracking of protein localization under physiological conditions [1, 2]. Knock-in of patient mutations can model disease-specific defects in nuclear import.
Overexpression
Overexpression of wild-type or mutant regulators (e.g., ACSS2, AHR) can enhance or disrupt nuclear localization and downstream signaling [1, 3]. This approach is useful for gain-of-function studies and for testing therapeutic hypotheses [1, 3].
How EDITGENE Supports positive regulation of protein localization to nucleus Research
Researchers studying positive regulation of protein localization to nucleus-related genes often need to determine whether a candidate gene is causally involved in nuclear transport, which requires precise genetic models. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of protein localization to nucleus research.
Frequently Asked Questions About positive regulation of protein localization to nucleus
What is GO:1900182?
GO:1900182 is a Gene Ontology term for positive regulation of protein localization to nucleus, describing any process that increases the frequency, rate, or extent of protein transport into the nucleus [1, 2].
What genes are involved in positive regulation of protein localization to nucleus?
Key genes include ACSS2, YAP, AHR, NSUN2, BZR1, TP53INP2, RACK1, and sphingosine kinase 2, as shown in recent studies [1, 2, 3, 4, 5, 8].
How is nuclear localization regulated?
It is regulated by post-translational modifications, signaling pathways, and interactions with scaffold proteins that expose or mask nuclear localization signals [5, 8].
Why is nuclear localization important in cancer?
Nuclear entry of oncogenic transcription factors like YAP and AHR drives gene expression programs that promote tumor growth and survival [2, 3].
What methods are used to study protein nuclear localization?
Common methods include fluorescence microscopy, subcellular fractionation, RNA-seq, proteomics, and CRISPR screens [1, 2, 5, 8].
Can CRISPR be used to study nuclear localization?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect the causal role of genes in nuclear transport [2, 5, 8].
What diseases are linked to defects in nuclear localization?
Cancer, bone homeostasis disorders, cognitive dysfunction, and autophagy-related diseases have been linked to altered nuclear localization [1, 2, 3, 4, 8].
What is the role of ACSS2 in nuclear localization?
Nuclear-translocated ACSS2 promotes gene transcription for lysosomal biogenesis and autophagy, linking metabolism to nuclear function.
How does Snhg18 regulate YAP localization?
Snhg18 regulates Yap subcellular localization to maintain bone homeostasis, and its loss leads to skeletal defects.
What is the function of TP53INP2 nuclear import?
TP53INP2 nuclear import is regulated by a C-terminal cytoplasmic retention motif and NLS, and it is involved in autophagy regulation.
Conclusion
GO:1900182, positive regulation of protein localization to nucleus, is a central biological process that controls how cells respond to signals by moving key proteins into the nucleus. The literature highlights diverse regulators, from metabolic enzymes like ACSS2 to scaffold proteins like RACK1, and underscores the importance of this process in cancer, bone homeostasis, and neurological function [1, 2, 3, 4, 5, 8]. Understanding these mechanisms requires precise genetic models, and CRISPR-based approaches are indispensable for dissecting causality [2, 5, 8]. EDITGENE offers a full suite of services to support researchers in this endeavor, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Li X et al.. 2017. Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal Biogenesis and Autophagy.. Mol Cell 66(5):684-697.e9 PMID: 28552616
- 2. Huang J et al.. 2025. Snhg18 regulates Yap subcellular localization to maintain bone homeostasis.. Nat Commun 16(1):7543 PMID: 40813368
- 3. Yokoyama S et al.. 2024. Sphingosine Kinase 2 Regulates Aryl Hydrocarbon Receptor Nuclear Translocation and Target Gene Activation.. Adv Sci (Weinh) 11(40):e2400794 PMID: 39207053
- 4. Gonskikh Y et al.. 2025. Spatial regulation of NSUN2-mediated tRNA m5C installation in cognitive function.. Nucleic Acids Res 53(2) PMID: 39673800
- 5. Li Z et al.. 2023. Scaffold protein RACK1 regulates BR signaling by modulating the nuclear localization of BZR1.. New Phytol 239(5):1804-1818 PMID: 37301989
- 6. Poli A et al.. 2014. Protein kinase C involvement in cell cycle modulation.. Biochem Soc Trans 42(5):1471-6 PMID: 25233434
- 7. An H et al.. 2019. Stress granules regulate stress-induced paraspeckle assembly.. J Cell Biol 218(12):4127-4140 PMID: 31636118
- 8. Shrestha BK et al.. 2025. A C-terminal cytoplasmic retention motif and nuclear localization signal regulates nuclear import of TP53INP2.. J Cell Sci 138(24) PMID: 41368677
